MAJOR DEPRESSIVE DISORDER IN DSM-5: IMPLICATIONS FOR CLINICAL PRACTICE AND RESEARCH OF CHANGES FROM DSM-IV-Reference-Cited by-同舟云学术

MAJOR DEPRESSIVE DISORDER IN DSM-5: IMPLICATIONS FOR CLINICAL PRACTICE AND RESEARCH OF CHANGES FROM DSM-IV

Published:2013-11-22 Issue:6 Volume:31 Page:459-471
ISSN:1091-4269
Container-title:Depression and Anxiety
language:en
Short-container-title:Depress Anxiety

Author:

Uher Rudolf¹²,Payne Jennifer L.³,Pavlova Barbara¹,Perlis Roy H.⁴

Affiliation:

1. Department of Psychiatry; Dalhousie University; Halifax Nova Scotia Canada

2. Institute of Psychiatry; King's College London; London UK

3. Department of Psychiatry; Johns Hopkins School of Medicine; Baltimore Maryland

4. Center for Experimental Drugs and Diagnostics; Department of Psychiatry and Center for Human Genetic Research; Massachusetts General Hospital; Boston Massachusetts

Publisher

Wiley

Subject

Psychiatry and Mental health,Clinical Psychology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/da.22217/fullpdf

Reference78 articles.

1. Diagnostic and Statistical Manual of Mental Disorders

2. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis;Cross-Disorder Group of the Psychiatric Genomics Consortium;Lancet,2013

3. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study;Lichtenstein;Lancet,2009

4. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs;Lee;Nat Genet,2013

5. Risk of mental illness in offspring of parents with schizophrenia, bipolar disorder, and major depressive disorder: a meta-analysis of family high-risk studies;Rasic;Schizophr Bull,2013

Cited by 285 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug metabolizing enzymes pharmacogenetic variation-informed antidepressant therapy approach for common mental disorders: A systematic review and meta-analysis;Journal of Affective Disorders;2024-12

2. Internet access during COVID-19 and depressive symptoms in middle-aged and older adults: Evidence from a quasi-experimental study in China;Journal of Affective Disorders;2024-12

3. Plasma alpha-trypsin inhibitor heavy chain 4 as an age-specific biomarker in the diagnosis and treatment of major depressive disorder;Frontiers in Psychiatry;2024-09-11

4. ElectroRetinoGraphy toward an exploration of the therapeutic potential of antidepressants in patients with major depressive disorder: A scoping review of the literature;Neuroscience & Biobehavioral Reviews;2024-09

5. A Computing System for Complex Cases of Major Recurrent Depression Based on Latent Semantic Analysis: Relationship between Life Themes and Symptoms;Big Data and Cognitive Computing;2024-08-05